CYTEK BIOSCIENCES, INC. Comprehensive Income
CYTEK BIOSCIENCES, INC. (CTKB) reported Comprehensive Income of -$11.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$11.79M.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$18.74M.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$42.66M, a 546.32% decline year-over-year.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$4.62M, a 473.40% decline year-over-year.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$64.31M.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$4.73M.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$12.73M, a 1529.89% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $890.00K, a 76.94% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$11.79M 10-Q · filed 2026-08-05 | -$30.53M 10-Q · filed 2026-08-05 | -$73.18M derived: sum of 3 quarters · filed 2026-08-05 | -$77.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$18.74M 10-Q · filed 2026-05-07 | -$61.39M derived: sum of 2 quarters · filed 2026-05-07 | -$66.01M derived: sum of 3 quarters · filed 2026-05-07 | -$71.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$42.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$47.27M derived: sum of 2 quarters · filed 2026-02-26 | -$52.29M derived: sum of 3 quarters · filed 2026-08-05 | -$64.31M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$4.62M 10-Q · filed 2025-11-05 | -$9.63M derived: sum of 2 quarters · filed 2026-08-05 | -$21.66M 10-Q · filed 2025-11-05 | -$12.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$5.01M 10-Q · filed 2026-08-05 | -$17.04M 10-Q · filed 2026-08-05 | -$7.48M derived: sum of 3 quarters · filed 2026-08-05 | -$6.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$12.03M 10-Q · filed 2026-05-07 | -$2.47M derived: sum of 2 quarters · filed 2026-05-07 | -$1.23M derived: sum of 3 quarters · filed 2026-05-07 | -$10.31M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $9.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.79M derived: sum of 2 quarters · filed 2026-02-26 | $1.72M derived: sum of 3 quarters · filed 2026-02-26 | -$4.73M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.24M 10-Q · filed 2025-11-05 | -$7.84M derived: sum of 2 quarters · filed 2025-11-05 | -$14.29M 10-Q · filed 2025-11-05 | -$8.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$9.07M 10-Q · filed 2025-08-06 | -$15.52M 10-Q · filed 2025-08-06 | -$9.72M derived: sum of 3 quarters · filed 2026-02-26 | -$15.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$6.45M 10-Q · filed 2025-05-08 | -$641.00K derived: sum of 2 quarters · filed 2026-02-26 | -$6.92M derived: sum of 3 quarters · filed 2026-02-26 | -$12.48M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$469.00K derived: sum of 2 quarters · filed 2026-02-26 | -$6.03M derived: sum of 3 quarters · filed 2026-02-26 | -$12.73M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$6.28M 10-Q · filed 2024-11-07 | -$11.84M derived: sum of 2 quarters · filed 2024-11-07 | -$18.53M 10-Q · filed 2024-11-07 | -$14.98M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$5.56M 10-Q · filed 2024-08-06 | -$12.26M 10-Q · filed 2024-08-06 | -$8.71M derived: sum of 3 quarters · filed 2025-02-28 | -$7.84M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$6.70M 10-Q · filed 2024-05-08 | -$3.15M derived: sum of 2 quarters · filed 2025-02-28 | -$2.28M derived: sum of 3 quarters · filed 2025-02-28 | -$3.66M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $4.42M derived: sum of 2 quarters · filed 2025-02-28 | $3.03M derived: sum of 3 quarters · filed 2025-02-28 | $890.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $868.00K 10-Q · filed 2023-11-14 | -$517.00K derived: sum of 2 quarters · filed 2023-11-14 | -$2.66M 10-Q · filed 2023-11-14 | -$3.50M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | -$1.39M 10-Q · filed 2023-08-08 | -$3.53M 10-Q · filed 2023-08-08 | -$4.37M derived: sum of 3 quarters · filed 2024-03-13 | -$2.91M derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | -$2.14M 10-Q · filed 2023-05-09 | -$2.98M derived: sum of 2 quarters · filed 2024-03-13 | -$1.53M derived: sum of 3 quarters · filed 2024-03-13 | $1.41M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | -$838.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $616.00K derived: sum of 2 quarters · filed 2024-03-13 | $3.56M derived: sum of 3 quarters · filed 2024-03-13 | $3.86M 10-K · filed 2024-03-13 |
| 2021-09-30 | $1.45M 10-Q · filed 2022-11-09 | $4.39M derived: sum of 2 quarters · filed 2022-11-09 | $4.70M 10-Q · filed 2022-11-09 | $10.46M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.94M 10-Q · filed 2022-08-10 | $3.24M 10-Q · filed 2022-08-10 | $9.01M derived: sum of 3 quarters · filed 2023-03-01 | $15.69M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $304.00K 10-Q · filed 2022-05-12 | $6.07M derived: sum of 2 quarters · filed 2023-03-01 | $12.75M derived: sum of 3 quarters · filed 2023-03-01 | $20.84M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $5.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $12.45M derived: sum of 2 quarters · filed 2023-03-01 | $20.54M derived: sum of 3 quarters · filed 2023-03-01 | $19.62M 10-K · filed 2023-03-01 |
| 2020-09-30 | $6.68M 10-Q · filed 2021-11-12 | $14.78M derived: sum of 2 quarters · filed 2021-11-12 | $13.86M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $8.09M 10-Q · filed 2021-09-03 | $7.18M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |